Dr. Chiaravalloti comments on trends in rehabilitation research in MS

Nancy Chiaravalloti, PhD, an expert in cognitive rehabilitation research, authored two commentaries on trends in multiple sclerosis (MS) research. Dr. Chiaravalloti is director of Neuropsychology & Neuroscience Research at Kessler Foundation. She was recently appointed director of Traumatic Brain Injury Research at the Foundation and also is principal investigator of the Northern New Jersey TBI System, a NIDRR-funded model system. Dr. Chiaravalloti is also an associate professor at UMDNJ-New Jersey Medical School.

Her editorial, "Applying functional MRI to the study of in " was published in the June issue of Imaging in Medicine (2012;4[3]:267-9) According to Dr. Chiaravalloti, neuroimaging with fMRI offers an objective method of documenting changes in cerebral activation with cognitive rehabilitation. This approach is yielding promising findings that may support the efficacy of cognitive rehabilitation for individuals with MS. Ongoing research requires the collaboration of scientists and clinicians knowledgeable in both cognitive rehabilitation and neuroimaging techniques.

The second editorial "Could behavioral therapies target specific deficits in multiple sclerosis patients?" appeared in Expert Reviews of Neurotherapeutics (2012;12[7]:755-7). Although cognitive impairments affect 40 to 70% of people with MS, research in cognitive rehabilitation research has been limited. Existing research indicates that the deficits in new learning, memory and processing speed that prevail in this population may respond to behavioral interventions.

Dr. Chiaravalloti's editorials were based on her research funded by an RO1 and Competitive Supplement (Improving Learning in : A Randomized Clinical Trial) from the NIH (NCMRR; grant 1R01HD045798 and HD045798S).

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Why upper motor neurons degenerate in ALS

4 hours ago

For the first time, scientists have revealed a mechanism underlying the cellular degeneration of upper motor neurons, a small group of neurons in the brain recently shown to play a major role in ALS pathology.

Study finds novel compound switches off epilepsy development

5 hours ago

Researchers at the LSU Health New Orleans Neuroscience Center of Excellence have found that a novel compound they discovered helps curtail the onset and progression of temporal lobe epilepsy. The finding, which may contribute ...

A challenge to expedite Genervon's new ASL drug

Jan 27, 2015

(Medical Xpress)—The Ice Bucket Challenge to raise awareness for Amyotrophic lateral sclerosis (ALS) went viral on social media last summer. Over 1.2 million videos were posted on Facebook alone. The difficulty ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.